Safety and immunogenicity of recombinant Bacille Calmette-Guerin (rBCG) expressing Borrelia burgdorferi outer surface protein A (OspA) lipoprotein in adult volunteers: a candidate Lyme disease vaccine

By Edelman R.   Palmer K.   Russ K.G.   Secrest H.P.   Anna L. Becker J.   Bodison S.A.   Perry J.G.   Sills A.R.   Barbour A.G.   Luke C.J.   Hanson M.S.   Stover C.K.   Burlein J.E.   Bansal G.P.   Connor E.M.   Koenig S.  

Vaccine, Vol. 17, Iss. 7, 1999-02 ,pp. : 904-914

Elsevier

Access to resources Recommend Favorite

Evaluation of the safety, reactogenicity and immunogenicity of three recombinant outer surface protein (OspA) lyme vaccines in healthy adults

By Van Hoecke C.   Comberbach M.   De Grave D.   Desmons P.   Fu D.   Hauser P.   Lebacq E.   Lobet Y.   Voet P.  

Vaccine, Vol. 14, Iss. 17, 1996-12 ,pp. : 1620-1626

Elsevier

Access to resources Recommend Favorite

The outer surface protein A (OspA) vaccine against Lyme disease: efficacy in the rhesus monkey

By Philipp M.T.   Lobet Y.   Bohm R.P.   Roberts E.D.   Dennis V.A.   Gu Y.   Lowrie R.C.   Desmons P.   Duray P.H.   England J.D.   Hauser P.   Piesman J.   Xu K.  

Vaccine, Vol. 15, Iss. 17, 1997-12 ,pp. : 1872-1887

Elsevier

Access to resources Recommend Favorite

Influence of administration dose and route on the immunogenicity and protective efficacy of BBG2Na, a recombinant respiratory syncytial virus subunit vaccine candidate

By Goetsch L.   Plotnicky-Gilquin H.   Champion T.   Beck A.   Corvaa N.   Stahl S.   Bonnefoy J.-Y.   Nguyen T.N.   Power U.F.  

Vaccine, Vol. 18, Iss. 24, 2000-06 ,pp. : 2735-2742

Elsevier

Access to resources Recommend Favorite

Community-based assessment of safety and immunogenicity of the whole cell plus recombinant B subunit (WC/rBS) oral cholera vaccine in Peru

By Begue R.E.   Castellares G.   Ruiz R.   Hayashi K.E.   Sanchez J.L.   Gotuzzo E.   Oberst R.B.   Taylor D.N.   Svennerholm A.-M.  

Vaccine, Vol. 13, Iss. 7, 1995-01 ,pp. : 691-694

Elsevier

Access to resources Recommend Favorite